Sulfonamide inhibitors: a patent review 2013-present
- PMID: 29886770
- DOI: 10.1080/13543776.2018.1487400
Sulfonamide inhibitors: a patent review 2013-present
Abstract
Introduction: Sulfonamide compounds are significant class of synthetic bacteriostatic antibiotics still which used today for the therapy of bacterial infections and those caused by other microorganisms. They are also known as sulfa drugs and were the main source of therapy against bacterial infections before the introduction of penicillin in 1941. Additionally, The first sulfonamide section is present inmany clinically used drugs such as diuretics, carbonic anhydrase inhibitors and antiepileptics.
Areas covered in this review: The article presents the main classes of sulfonamide inhibitors investigated between 2013 and present. Specifically, the authors review the scientific and patent literature on tyrosine kinase, human immunodeficieny virus protease-1 (HIV‑1), histone deacetylase 6, protein tyrosine phosphatase 1B, sphingosine kinase, phosphatidyl inositol 3-kinase, angiogenesis, pyrazole kinase, tyrosyl DNA phosphodiesterase inhibitors were evaluated. Expert opinion: Sulfonamides are utilized as the antiviral HIV protease inhibitor amprenavir, as an anticancer agent, and in Alzheimer's disease drugs. All these data show that although known for more than 100 years, the primary sulfonamides constitute an important class of compounds which leads to highly valuable drugs and drug candidates for many conditions, such as cancer, glaucoma, inflammation, dandruff, just to mention the most investigated ones.
Keywords: HIV‑1 protease; Histone deacetylase 6; Sulfonamide; Tyrosine kinase; enzyme inhibitor; protein tyrosine phosphatase 1B; pyrazole kinase; sphingosine kinase; tyrosyl DNA phosphodiesterase.
Similar articles
-
Sulfonamides: a patent review (2008 - 2012).Expert Opin Ther Pat. 2012 Jul;22(7):747-58. doi: 10.1517/13543776.2012.698264. Epub 2012 Jun 15. Expert Opin Ther Pat. 2012. PMID: 22697257 Review.
-
Anticancer and antiviral sulfonamides.Curr Med Chem. 2003 Jun;10(11):925-53. doi: 10.2174/0929867033457647. Curr Med Chem. 2003. PMID: 12678681 Review.
-
Secondary and tertiary sulfonamides: a patent review (2008 - 2012).Expert Opin Ther Pat. 2013 Feb;23(2):203-13. doi: 10.1517/13543776.2013.742065. Epub 2012 Nov 14. Expert Opin Ther Pat. 2013. PMID: 23148584 Review.
-
Protease inhibitors of the sulfonamide type: anticancer, antiinflammatory, and antiviral agents.Med Res Rev. 2003 Sep;23(5):535-58. doi: 10.1002/med.10047. Med Res Rev. 2003. PMID: 12789686 Review.
-
Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 - 2013).Expert Opin Ther Pat. 2013;23(6):681-91. doi: 10.1517/13543776.2013.780598. Epub 2013 Mar 14. Expert Opin Ther Pat. 2013. PMID: 23488823 Review.
Cited by
-
Synthesis of Novel Bromophenol with Diaryl Methanes-Determination of Their Inhibition Effects on Carbonic Anhydrase and Acetylcholinesterase.Molecules. 2022 Nov 1;27(21):7426. doi: 10.3390/molecules27217426. Molecules. 2022. PMID: 36364255 Free PMC article.
-
Synthesis of Fulvene Vinyl Ethers by Gold Catalysis.Chemistry. 2020 Apr 21;26(23):5280-5287. doi: 10.1002/chem.202000338. Epub 2020 Apr 6. Chemistry. 2020. PMID: 32092204 Free PMC article.
-
Targeting the interaction of AIMP2-DX2 with HSP70 suppresses cancer development.Nat Chem Biol. 2020 Jan;16(1):31-41. doi: 10.1038/s41589-019-0415-2. Epub 2019 Dec 2. Nat Chem Biol. 2020. PMID: 31792442
-
Synthesis and Biological Evaluation of NH2-Sulfonyl Oseltamivir Analogues as Influenza Neuraminidase Inhibitors.Molecules. 2019 Jun 10;24(11):2176. doi: 10.3390/molecules24112176. Molecules. 2019. PMID: 31185617 Free PMC article.
-
Coumarins and Gastrointestinal Cancer: A New Therapeutic Option?Front Oncol. 2021 Oct 11;11:752784. doi: 10.3389/fonc.2021.752784. eCollection 2021. Front Oncol. 2021. PMID: 34707995 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources